• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶 A 介导的 ATXN1-S776 磷酸化减少可延迟 SCA1 小鼠模型中小脑浦肯野细胞的发病。

Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model.

机构信息

Institute for Translational Neuroscience, University of Minnesota, Minneapolis, MN, United States; Graduate Program in Neuroscience, University of Minnesota, Minneapolis, MN, United States.

Institute for Translational Neuroscience, University of Minnesota, Minneapolis, MN, United States; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States.

出版信息

Neurobiol Dis. 2018 Aug;116:93-105. doi: 10.1016/j.nbd.2018.05.002. Epub 2018 May 11.

DOI:10.1016/j.nbd.2018.05.002
PMID:29758256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6028938/
Abstract

Spinocerebellar ataxia type 1 (SCA1) is a polyglutamine (polyQ) repeat neurodegenerative disease in which a primary site of pathogenesis are cerebellar Purkinje cells. In addition to polyQ expansion of ataxin-1 protein (ATXN1), phosphorylation of ATXN1 at the serine 776 residue (ATXN1-pS776) plays a significant role in protein toxicity. Utilizing a biochemical approach, pharmacological agents and cell-based assays, including SCA1 patient iPSC-derived neurons, we examine the role of Protein Kinase A (PKA) as an effector of ATXN1-S776 phosphorylation. We further examine the implications of PKA-mediated phosphorylation at ATXN1-S776 on SCA1 through genetic manipulation of the PKA catalytic subunit Cα in Pcp2-ATXN1[82Q] mice. Here we show that pharmacologic inhibition of S776 phosphorylation in transfected cells and SCA1 patient iPSC-derived neuronal cells lead to a decrease in ATXN1. In vivo, reduction of PKA-mediated ATXN1-pS776 results in enhanced degradation of ATXN1 and improved cerebellar-dependent motor performance. These results provide evidence that PKA is a biologically important kinase for ATXN1-pS776 in cerebellar Purkinje cells.

摘要

脊髓小脑共济失调 1 型(SCA1)是一种多聚谷氨酰胺(polyQ)重复的神经退行性疾病,其发病的主要部位是小脑浦肯野细胞。除了 ATXN1 蛋白的 polyQ 扩展外,丝氨酸 776 残基(ATXN1-pS776)的 ATXN1 磷酸化在蛋白毒性中起着重要作用。利用生化方法、药理学制剂和基于细胞的测定法,包括 SCA1 患者诱导多能干细胞衍生的神经元,我们研究了蛋白激酶 A(PKA)作为 ATXN1-S776 磷酸化效应物的作用。我们通过 Pcp2-ATXN1[82Q]小鼠中 PKA 催化亚基 Cα 的遗传操作进一步研究了 PKA 介导的 ATXN1-S776 磷酸化对 SCA1 的影响。在这里,我们表明在转染细胞和 SCA1 患者诱导多能干细胞衍生的神经元细胞中,S776 磷酸化的药理学抑制导致 ATXN1 的减少。在体内,减少 PKA 介导的 ATXN1-pS776 导致 ATXN1 的降解增强和小脑依赖性运动性能的改善。这些结果提供了证据表明 PKA 是小脑浦肯野细胞中 ATXN1-pS776 的一种重要的生物学激酶。

相似文献

1
Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model.蛋白激酶 A 介导的 ATXN1-S776 磷酸化减少可延迟 SCA1 小鼠模型中小脑浦肯野细胞的发病。
Neurobiol Dis. 2018 Aug;116:93-105. doi: 10.1016/j.nbd.2018.05.002. Epub 2018 May 11.
2
Phosphorylation of ATXN1 at Ser776 in the cerebellum.小脑内Ataxin-1(ATXN1)在丝氨酸776位点的磷酸化。
J Neurochem. 2009 Jul;110(2):675-86. doi: 10.1111/j.1471-4159.2009.06164.x. Epub 2009 May 15.
3
Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1.调节 ATXN1 S776 磷酸化揭示了 SCA1 中等位基因特异性靶向的重要性。
JCI Insight. 2021 Feb 8;6(3):144955. doi: 10.1172/jci.insight.144955.
4
Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.多巴胺 D2 受体信号调节突变型共济失调蛋白 1 S776 磷酸化和聚集。
J Neurochem. 2010 Aug;114(3):706-16. doi: 10.1111/j.1471-4159.2010.06791.x. Epub 2010 Apr 30.
5
Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.共济失调蛋白1的丝氨酸776对于SCA1转基因小鼠中多聚谷氨酰胺诱导的疾病至关重要。
Neuron. 2003 May 8;38(3):375-87. doi: 10.1016/s0896-6273(03)00258-7.
6
Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies.脊髓小脑共济失调 1 型:神经退行性变的分子机制和临床前研究。
Adv Exp Med Biol. 2018;1049:135-145. doi: 10.1007/978-3-319-71779-1_6.
7
SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.SCA1 磷酸化,一种调节 Ataxin-1 功能和发病机制的物质。
Prog Neurobiol. 2012 Dec;99(3):179-85. doi: 10.1016/j.pneurobio.2012.04.003. Epub 2012 Apr 16.
8
Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.ATXN1转基因小鼠的小脑转录组图谱揭示脊髓小脑共济失调1型疾病进展和保护途径。
Neuron. 2016 Mar 16;89(6):1194-1207. doi: 10.1016/j.neuron.2016.02.011. Epub 2016 Mar 3.
9
The design and delivery of a PKA inhibitory polypeptide to treat SCA1.用于治疗脊髓小脑共济失调1型(SCA1)的蛋白激酶A(PKA)抑制多肽的设计与递送
J Neurochem. 2014 Oct;131(1):101-14. doi: 10.1111/jnc.12782. Epub 2014 Jun 23.
10
BDNF is altered in a brain-region specific manner and rescues deficits in Spinocerebellar Ataxia Type 1.脑源性神经营养因子(BDNF)在特定脑区发生改变,并可挽救脊髓小脑共济失调 1 型的缺陷。
Neurobiol Dis. 2023 Mar;178:106023. doi: 10.1016/j.nbd.2023.106023. Epub 2023 Jan 29.

引用本文的文献

1
The Role of Protein Quantity Control in Polyglutamine Spinocerebellar Ataxias.蛋白质量控制在多聚谷氨酰胺小脑共济失调中的作用。
Cerebellum. 2024 Dec;23(6):2575-2592. doi: 10.1007/s12311-024-01722-w. Epub 2024 Jul 25.
2
Functional implications of paralog genes in polyglutamine spinocerebellar ataxias.多聚谷氨酰胺小脑共济失调相关基因的功能意义。
Hum Genet. 2023 Dec;142(12):1651-1676. doi: 10.1007/s00439-023-02607-4. Epub 2023 Oct 16.
3
Widespread alternative splicing dysregulation occurs presymptomatically in CAG expansion spinocerebellar ataxias.

本文引用的文献

1
Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia.蛋白激酶 C 活性是小脑共济失调中浦肯野神经元变性的保护性修饰因子。
Hum Mol Genet. 2018 Apr 15;27(8):1396-1410. doi: 10.1093/hmg/ddy050.
2
Expansion, mosaicism and interruption: mechanisms of the CAG repeat mutation in spinocerebellar ataxia type 1.扩展、嵌合现象与中断:1型脊髓小脑共济失调中CAG重复突变的机制
Cerebellum Ataxias. 2016 Nov 22;3:20. doi: 10.1186/s40673-016-0058-y. eCollection 2016.
3
Stabilization and Degradation Mechanisms of Cytoplasmic Ataxin-1.
广泛性的选择性剪接失调发生在 CAG 扩展脊髓小脑共济失调的症状前。
Brain. 2024 Feb 1;147(2):486-504. doi: 10.1093/brain/awad329.
4
Therapeutic Strategies for Spinocerebellar Ataxia Type 1.脊髓小脑共济失调 1 型的治疗策略。
Biomolecules. 2023 May 2;13(5):788. doi: 10.3390/biom13050788.
5
Decreasing mutant ATXN1 nuclear localization improves a spectrum of SCA1-like phenotypes and brain region transcriptomic profiles.降低突变 ATXN1 的核定位可改善一系列 SCA1 样表型和大脑区域转录组图谱。
Neuron. 2023 Feb 15;111(4):493-507.e6. doi: 10.1016/j.neuron.2022.11.017. Epub 2022 Dec 27.
6
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells.通过 CRISPR/Cas9 系统抑制 SCA1 细胞中的功能获得性蛋白。
Sci Rep. 2022 Nov 24;12(1):20285. doi: 10.1038/s41598-022-24299-y.
7
Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1.鉴定共济失调蛋白 1 相互作用网络及其对脊髓小脑共济失调 1 型的影响。
Hum Genomics. 2022 Jul 29;16(1):29. doi: 10.1186/s40246-022-00404-0.
8
Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling.基于神经退行性疾病患者特异性 iPSC 的模型:聚焦于异常钙信号。
Int J Mol Sci. 2022 Jan 6;23(2):624. doi: 10.3390/ijms23020624.
9
Intercellular Propagation and Aggregate Seeding of Mutant Ataxin-1.突变型共济失调蛋白-1 的细胞间传播和聚集播种。
J Mol Neurosci. 2022 Apr;72(4):708-718. doi: 10.1007/s12031-021-01944-1. Epub 2021 Nov 26.
10
New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors.基因治疗在多聚谷氨酰胺脊髓小脑共济失调方面的新视角:从分子靶点到新型纳米载体
Pharmaceutics. 2021 Jul 3;13(7):1018. doi: 10.3390/pharmaceutics13071018.
细胞质中ataxin-1的稳定与降解机制
J Exp Neurosci. 2016 May 5;9(Suppl 2):123-9. doi: 10.4137/JEN.S25469. eCollection 2015.
4
Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.ATXN1转基因小鼠的小脑转录组图谱揭示脊髓小脑共济失调1型疾病进展和保护途径。
Neuron. 2016 Mar 16;89(6):1194-1207. doi: 10.1016/j.neuron.2016.02.011. Epub 2016 Mar 3.
5
Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1.1型脊髓小脑共济失调小鼠模型中微胶质细胞和星形胶质细胞的早期激活
Neuroscience. 2015 Mar 19;289:289-99. doi: 10.1016/j.neuroscience.2015.01.003. Epub 2015 Jan 14.
6
The design and delivery of a PKA inhibitory polypeptide to treat SCA1.用于治疗脊髓小脑共济失调1型(SCA1)的蛋白激酶A(PKA)抑制多肽的设计与递送
J Neurochem. 2014 Oct;131(1):101-14. doi: 10.1111/jnc.12782. Epub 2014 Jun 23.
7
Trimmomatic: a flexible trimmer for Illumina sequence data.Trimmomatic:一款适用于 Illumina 测序数据的灵活修剪工具。
Bioinformatics. 2014 Aug 1;30(15):2114-20. doi: 10.1093/bioinformatics/btu170. Epub 2014 Apr 1.
8
Hereditary ataxia: a pathologic study of five cases of common ancestry.遗传性共济失调:对五例有共同祖先病例的病理学研究。
J Neuropathol Clin Neurol. 1951 Jul;1(3):183-213.
9
Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.深脑核内 RNAi 表达载体递送后广泛的治疗获益:对脊髓小脑共济失调 1 型治疗的启示。
Mol Ther. 2014 Mar;22(3):588-595. doi: 10.1038/mt.2013.279. Epub 2013 Dec 12.
10
Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology.结构导向抑制剂设计拓展了模拟敏感激酶技术的应用范围。
ACS Chem Biol. 2013 Sep 20;8(9):1931-8. doi: 10.1021/cb400376p. Epub 2013 Jul 23.